Antiretroviral Therapy in Pregnancy: A Focus on Safety

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.9, 2001-01, pp. : 683-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The safety of antiretroviral drugs in pregnancy

By Thorne Claire Newell Marie-Louise

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 323-335

Informa Healthcare

Access to resources Recommend Favorite

Adverse effects of antiretroviral therapy: focus on bone density

By Viganò Alessandra Mora Stefano

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 199-208

Informa Healthcare

Access to resources Recommend Favorite

Adverse effects of antiretroviral therapy: focus on orofacial effects

By Dios Pedro Diz Scully Crispian

Expert Opinion on Drug Safety, Vol. 1, Iss. 4, 2002-11 ,pp. : 307-317

Informa Healthcare

Access to resources Recommend Favorite

The safety of antithrombotic therapy during pregnancy

By Ageno Walter Crotti Stefania Turpie Alexander GG

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 113-118

Informa Healthcare

Access to resources Recommend Favorite

Antiretroviral Therapy for Prevention of Mother-to-Child HIV Transmission: Focus on Single-Dose Nevirapine

By Giaquinto Carlo

Clinical Drug Investigation, Vol. 26, Iss. 11, 2006-01 ,pp. : 611-627

Adis International

Access to resources Recommend Favorite